dc.contributor.author |
Arroyo Hurtado, Gianfranco |
|
dc.contributor.author |
Bustos Palomino, Javier Arturo |
|
dc.contributor.author |
Lescano Guevara, Andres Guillermo |
|
dc.contributor.author |
Gonzales, Isidro |
|
dc.contributor.author |
Saavedra Pastor, Herbert |
|
dc.contributor.author |
Pretell, E. Javier |
|
dc.contributor.author |
Castillo Berrios, Yesenia |
|
dc.contributor.author |
Perez, Erika |
|
dc.contributor.author |
Handali, Sukwan |
|
dc.contributor.author |
Noh, John |
|
dc.contributor.author |
Dorny, Pierre |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
O'Neal, Seth E. |
|
dc.contributor.author |
Gonzalez Zariquiey, Armando Emiliano |
|
dc.contributor.author |
García Lescano, Héctor Hugo |
|
dc.date.accessioned |
2022-02-01T21:18:26Z |
|
dc.date.available |
2022-02-01T21:18:26Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/11266 |
|
dc.description.abstract |
The diagnosis of neurocysticercosis (NCC) depends on neuroimaging and serological confirmation. While antibody detection by enzyme-linked immunoelectrotransfer blot (EITB) fails to predict viable NCC, EITB banding patterns provide information about the host's infection course. Adding antigen enzyme-linked immunosorbent assay (Ag-ELISA) results to EITB banding patterns may improve their ability to predict or rule out of viable NCC. We assessed whether combining EITB banding patterns with Ag-ELISA improves discrimination of viable infection in imaging-confirmed parenchymal NCC. EITB banding patterns were grouped into classes using latent class analysis. True-positive and false-negative Ag-ELISA results in each class were compared using Fisher's exact test. Four classes were identified: 1, EITB negative or positive to GP50 alone (GP50 antigen family); 2, positive to GP42-39 and GP24 (T24/42 family), with or without GP50; and 3 and 4, positive to GP50, GP42-39, and GP24 and reacting to bands in the 8-kDa family. Most cases in classes 3 and 4 had viable NCC (82% and 88%, respectively) compared to classes 2 and 1 (53% and 5%, respectively). Adding positive Ag-ELISA results to class 2 predicted all viable NCC cases (22/22 [100%]), whereas 11/40 patients (27.5%) Ag-ELISA negative had viable NCC (P < 0.001). Only 1/4 patients (25%) Ag-ELISA positive in class 1 had viable NCC, whereas 1/36 patients (2.8%) Ag-ELISA negative had viable NCC (P = 0.192). In classes 3 and 4, adding Ag-ELISA was not contributory. Combining Ag-ELISA with EITB banding patterns improves discrimination of viable from nonviable NCC, particularly for class 2 responses. Together, these complement neuroimaging more appropriately for the diagnosis of viable NCC. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
American Society for Microbiology |
|
dc.relation.ispartofseries |
Journal of Clinical Microbiology |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Ag-ELISA |
en_US |
dc.subject |
EITB banding patterns |
en_US |
dc.subject |
Taenia solium |
en_US |
dc.subject |
Viable NCC |
en_US |
dc.title |
Improved diagnosis of viable parenchymal neurocysticercosis by combining antibody banding patterns on enzyme-linked immunoelectrotransfer blot (EITB) with antigen ELISA assay. |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1128/JCM.01550-21 |
|
dc.relation.issn |
1098-660X |
|